近期论文
查看导师新发文章
(温馨提示:请注意重名现象,建议点开原文通过作者单位确认)
1.Zhiwei Huang, Xiaomin Shi, Richard S Sucgang & Xuewen Pan. A functional variomic tool in Saccharomyces cerevisiae. 2010 (Submitted).
2.Zhiwei Huang, Xiaomin Shi, Xuewen Pan. Strategies for high efficiency allele integration in Saccharomyces cerevisiae.2010? (Submitted).
3.Xuewen Pan, Stefanie Reissman, Nick R. Douglas, Zhiwei Huang, Daniel S. Yuan, Xiaoling Wang, J. Michael McCaffery, Judith Frydman and Jef D. Boeke. Trivalent Arsenic Inhibits the Functions of Chaperonin Complex. Genetics, Jul. 2010 (Available online).
4.Zhiwei Huang, Guichen Chen, Ping Shi. Effects of emodin on the gene expression profiling of human breast carcinoma cells. Cancer detection and prevention. 2009, 32: 286-291
5.Zhiwei Huang, Richard S Sucgang, Yu-yi Lin, Xiaomin Shi, Jef D Boeke & Xuewen Pan. Plasmid-chromosome shuffling for non-deletion alleles in yeast. Nature Methods. 2008 Feb;5(2):167-9.
6.Zhang J, Shi X, Li Y, Kim BJ, Jia J, Huang Z, Yang T, Fu X, Jung SY, Wang Y, Zhang P, Kim ST, Pan X, Qin J. Acetylation of Smc3 by Eco1 is required for S phase sister chromatid cohesion in both human and yeast. Mol Cell. 2008 Jul 11;31(1):143-51.
7.Zhiwei Huang, Guichen Chen, Ping Shi. Emodin-induced apoptosis in human breast cancer BCap-37 cells through mitochondrial signaling pathway. Archives of pharmacal research. 2008, 31(6):742-748.
8.Ping Shi, Zhiwei Huang, Xiaorong Tan, Guichen Chen. Proteomic detection of changes in protein expression induced by cordycepin in human hepatocelluar carcinoma BEL-7402 cells. Methods and findings in experimental and clinical pharmacology. 2008 Jun;30(5):347-53
9.Ping Shi, Zhiwei Huang, Guichen Chen. Rhein induces apoptosis and cell cycle arrest in human hepatocelluar carcinoma BEL-7402 cells. The American journal of Chinese Medicine. 2008;36(4):805-13
10.Zhiwei Huang, Ping Shi, Guichen Chen, Jiawei Du.? Effects of azadirachtin on hemolymph protein expression in Ostrinia furnacalis (Lepidoptera: Crambidae). Annals of the Entomological Society of America. 2007,100 (2):245-250.